Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
Top Cited Papers
- 1 April 2003
- journal article
- clinical trial
- Published by Elsevier in Gastroenterology
- Vol. 124 (4) , 889-893
- https://doi.org/10.1053/gast.2003.50156
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- The Risk for Cancer Or Dysplasia in Ulcerative Colitis Patients With Primary Sclerosing CholangitisAmerican Journal of Gastroenterology, 1999
- CANCER RISK IN PATIENTS WITH INFLAMMATORY BOWEL DISEASEGastroenterology Clinics of North America, 1999
- Primary sclerosing cholangitis and colorectal carcinoma in patients with chronic ulcerative colitisCancer, 1998
- Different bile acids exhibit distinct biological effects: The tumor promoter deoxycholic acid induces apoptosis and the chemopreventive agent ursodeoxycholic acid inhibits cell proliferationNutrition and Cancer, 1998
- Is there an excess risk for colorectal cancer in patients with ulcerative colitis and concomitant primary sclerosing cholangitis? A population based studyGut, 1997
- Colorectal Dysplasia and Carcinoma in Patients with Ulcerative Colitis and Primary Sclerosing CholangitisScandinavian Journal of Gastroenterology, 1997
- Risk of colorectal neoplasia in patients with primary sclerosing cholangitisGastroenterology, 1996
- Risk and natural history of colonic neoplasia in patients with primary sclerosing cholangitis and ulcerative colitisGastroenterology, 1996
- Colorectal neoplasia in patients with ulcerative colitis and primary sclerosing cholangitisDiseases of the Colon & Rectum, 1995
- Primary sclerosing cholangitis in ulcerative colitis—A risk factor for the development of dysplasia and DNA aneuploidy?Gastroenterology, 1992